1. Home
  2. BEAM vs KSS Comparison

BEAM vs KSS Comparison

Compare BEAM & KSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • KSS
  • Stock Information
  • Founded
  • BEAM 2017
  • KSS 1962
  • Country
  • BEAM United States
  • KSS United States
  • Employees
  • BEAM N/A
  • KSS N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • KSS Department/Specialty Retail Stores
  • Sector
  • BEAM Health Care
  • KSS Consumer Discretionary
  • Exchange
  • BEAM Nasdaq
  • KSS Nasdaq
  • Market Cap
  • BEAM 1.9B
  • KSS 1.9B
  • IPO Year
  • BEAM 2020
  • KSS 1992
  • Fundamental
  • Price
  • BEAM $25.05
  • KSS $17.04
  • Analyst Decision
  • BEAM Buy
  • KSS Hold
  • Analyst Count
  • BEAM 11
  • KSS 8
  • Target Price
  • BEAM $45.90
  • KSS $20.63
  • AVG Volume (30 Days)
  • BEAM 1.3M
  • KSS 7.2M
  • Earning Date
  • BEAM 11-05-2024
  • KSS 11-26-2024
  • Dividend Yield
  • BEAM N/A
  • KSS 11.74%
  • EPS Growth
  • BEAM N/A
  • KSS N/A
  • EPS
  • BEAM N/A
  • KSS 2.54
  • Revenue
  • BEAM $349,643,000.00
  • KSS $17,124,000,000.00
  • Revenue This Year
  • BEAM N/A
  • KSS N/A
  • Revenue Next Year
  • BEAM $6.04
  • KSS N/A
  • P/E Ratio
  • BEAM N/A
  • KSS $6.70
  • Revenue Growth
  • BEAM 328.73
  • KSS N/A
  • 52 Week Low
  • BEAM $20.84
  • KSS $16.12
  • 52 Week High
  • BEAM $49.50
  • KSS $29.60
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 50.63
  • KSS 40.89
  • Support Level
  • BEAM $23.67
  • KSS $16.12
  • Resistance Level
  • BEAM $25.87
  • KSS $18.73
  • Average True Range (ATR)
  • BEAM 2.22
  • KSS 0.79
  • MACD
  • BEAM -0.20
  • KSS -0.13
  • Stochastic Oscillator
  • BEAM 33.15
  • KSS 31.51

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About KSS Kohl's Corporation

Kohl's operates about 1,176 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also operates a large digital sales business. Women's apparel is Kohl's largest category, having generated 26% of its 2023 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.

Share on Social Networks: